Drugs for diabetes and obesity, such as “Ozempic,” are associated with reduced cancer risk - research

2024/7/6 3:55 JST (some excerpts)
This study is based on electronic medical records of more than 1.6 million people with type 2 diabetes
Early evidence about GLP-1 is “persuasive” - Kamal
New research suggests that weight loss drugs and diabetes treatment drugs, which are a big hit, may lower the risk of developing some common cancers closely related to obesity.